Literature DB >> 1703771

What can we expect from myeloid growth factors?

M H Bronchud1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1703771     DOI： 10.1016/0277-5379(90)90611-v

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  1 in total

1.  Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.

Authors:  M Nobbenhuis; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.